Vaccination with polysaccharide-conjugate-vaccines in adult patients with specific antibody deficiency

Vaccine

Volumn 24, Issue 17, 2006, Pages 3574-3580

  Shrimpton, Anna ^a   Duddridge, Michael ^a   Ziegler Heitbrock, Loems ^a,b,c  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Polysaccharides; Specific antibody deficiency; Vaccination

Indexed keywords

POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE; TETANUS TOXOID;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMORAL IMMUNE DEFICIENCY; PRIORITY JOURNAL; SEROTYPE; VACCINATION;

ADULT; AGED; ANTIBODIES, BACTERIAL; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; VACCINATION; VACCINES, CONJUGATE;

EID: 33645221634     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.063     Document Type: Article

References (36)

1. D.M. Ambrosino, G.R. Siber, B.A. Chilmonczyk, J.B. Jernberg, and R.W. Finberg An immundeficiency characterized by impaired antibody responses to polysaccharides N Eng J Med 316 1987 790 793
2. J.J. Mond, A. Lees, and C.M. Snapper T cell-independent antigens type 2 Annu Rev Immunol 13 1995 655 692
3. G. Lal, P. Balmer, E. Stanford, S. Martin, R. Warrington, and R. Borrow Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes J Immunol Methods 296 2005 135 147
4. J.V. Stavros, R.W. Wright, and D.M. Swingle Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions Anal Biochem 156 1986 220 222
5. S.A. Quataert, C.S. Kirch, L.J. Wiedl, D.C. Phipps, S. Strohmeyer, and C. Cimino Assignment of weight-based antibody units to a human anti-pneumococcal standard reference serum, lot 89-S Clin Diagn Lab Immunol 2 1995 590 597
6. N. Concepcion, and C.E. Frasch Pneumoccal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay Clin Diagn Lab Immunol 8 2001 266 272
7. World Health Organisation. Pneumococcal vaccines. WHO position paper. Weekly Epidemiol. Rec. 1999;74 (23):177-83.
8. Advisory Committee on Immunization Practices. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 1997;46 (RR-8):1-24.
9. J.C. Butler, R.F. Breiman, J.F. Campbell, H.B. Lipman, C.V. Broome, and R.R. Facklam Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations JAMA 270 15 1993 1826 1831
10. J. Hedlund, A. Ortqvist, H.B. Konradsen, and M. Kalin Recurrence of pneumonia in relation to the antibody response after pneumococcal vaccination in middle-aged and elderly adults Scand J Infect Dis 32 3 2000 281 286
11. A. Ortqvist, J. Hedlund, L.A. Burman, E. Elbel, M. Hofer, and M. Leinonen Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people Swedish Pneumococcal Vaccination Study Group Lancet 351 9100 1998 399 403
12. U. Sankilampi, P.O. Honkanen, A. Bloigu, E. Herva, and M. Leinonen Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly J Infect Dis 173 2 1996 387 393
13. E.D. Shapiro, A.T. Berg, R. Austrian, D. Schroeder, V. Parcells, and A. Margolis The protective efficacy of polyvalent pneumococcal polysaccharide vaccine N Engl J Med 325 21 1991 1453 1460
14. J. Gaillat, D. Zmirou, M.R. Mallaret, D. Rouhan, J.P. Bru, and J.P. Stahl Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions Rev Epidemiol Sante Publique 33 6 1985 437 444
15. K.L. Nichol The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease Vaccine 17 Suppl. 1 1999 S91 S93
16. K.L. Nichol, L. Baken, J. Wuorenma, and A. Nelson The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease Arch Intern Med 159 20 1999 2437 2442
17. P.O. Honkanen, T. Keistinen, L. Miettinen, E. Herva, U. Sankilampi, and E. Laara Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older Vaccine 17 20-21 1999 2493 2500
18. L.A. Jackson, K.M. Neuzil, O. Yu, P. Benson, W.E. Barlow, and A.L. Adams Effectiveness of pneumococcal polysaccharide vaccine in older adults N Engl J Med 348 18 2003 1747 1755
19. B. Christenson, P. Lundbergh, J. Hedlund, and A. Ortqvist Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study Lancet 357 2001 1008 1011
20. M. Menzel, B. Muellinger, N. Weber, K. Haeussinger, and L. Ziegler-Heitbrock Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers Vaccine 23 2005 5113 5119
21. T. Wuorimaa, and H. Kayhty Current state of pneumococcal vaccines Scand J Immunol 56 2002 111 129
22. C.G. Whitney, M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, and R. Lynfield Network. ABCSotEIP. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 2003 1737 1746
23. F. Gigliotti, H.G. Herrod, D.K. Kalwinsky, and R.A. Insel Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides Pediatr Infect Dis J 7 1988 417 420
24. H.G. Herrod, S. Gross, and R. Insel Selective antibody deficiency to Haemophilus influenzae type B capsular polysaccharide vaccination in children with recurrent respiratory tract infection J Clin Immunol 9 1989 429 434
25. O. Sanal, F. Ersoy, I. Tezcan, A. Metin, T. Turul, and S. Gariboglu Antibody response to a seven-valent pneumococcal conjugated vaccine in patients with ataxia-telangiectasia J Clin Immunol 24 2004 411 417
26. A. Stray-Pedersen, T. Jonsson, A. Heiberg, C.R. Lindman, E. Widing, and I.S. Aaberge The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents Clin Exp Immunol 137 2004 179 186
27. A. Stray-Pedersen, I.S. Aaberge, A. Fruh, and T.G. Abrahamsen Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine: immunogenicity in patients with ataxia-telangiectasia Clin Exp Immunol 140 2005 507 516
28. S. Zielen, I. Buhring, N. Strnad, J. Reichenbach, and D. Hofmann Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine Infect Immun 68 2000 1435 1440
29. R. Lakshman, A.R. Gennery, P.D. Arkwright, T. Flood, M. Abinun, and G. Spickett Assessing immune responses to pneumococcal vaccines Arch Dis Child 88 2003 648 649
30. R. Borrow, D. Goldblatt, N. Andrews, P. Richmond, J. Southern, and E. Miller Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children J Infect Dis 184 2001 377 380
31. R. Borrow, J. Southern, N. Andrews, N. Peake, R. Rahim, and M. Acuna Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naive controls Vaccine 19 2001 3043 3050
32. L. Jodar, J. Butler, G. Carlone, R. Dagan, D. Goldblatt, and H. Kayhty Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants Vaccine 21 2003 3265 3272
33. J.T. Jokinen, H. Ahman, T.M. Kilpi, P.H. Makela, and M.H. Kayhty Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media J Infect Dis 190 2004 545 550
34. J. Fernandez, O.S. Levine, J. Sanchez, S. Balter, L. LaClaire, J. Feris The Hib Vaccine Evaluation Team Prevention of H influenzae Type b colonisation by vaccination: correlation with serum anti-capsular IgG concentration J Infect Dis 182 2000 1553 1556
35. D. Goldblatt, M. Hussain, N. Andrews, L. Ahston, C. Virta, and A. Melegaro Antibody responses to nasopharyngeal carriage of S. pneumoniae in adults: a longitudinal household study J Inf Dis 192 2005 387 393
36. M.R. Wessels, and D.L. Kasper Antibody recognition of the type 14 pneumococcal capsule J Exp Med 169 1989 2121 2131